1. Clinical Impact of β-Lactamase-producing Enterobacteriaceae in Sputum of Cystic Fibrosis Patients.
- Author
-
Mussaffi H, Shvalb NF, Ben-Zvi H, Livni G, Mei-Zahav M, Prais D, Stafler P, Steuer G, and Blau H
- Subjects
- Adolescent, Adult, Carrier State microbiology, Child, Child, Preschool, Cohort Studies, Cystic Fibrosis complications, Enterobacteriaceae Infections epidemiology, Female, Hospitalization, Humans, Infant, Israel epidemiology, Male, Middle Aged, Prevalence, Young Adult, Cystic Fibrosis microbiology, Enterobacteriaceae enzymology, Enterobacteriaceae isolation & purification, Enterobacteriaceae Infections microbiology, Sputum microbiology, beta-Lactamases metabolism
- Abstract
This case series describes 18 cystic fibrosis (CF) patients of a 135-patient CF center cohort with extended spectrum β-lactamase-producing Enterobacteriaceae, from 2003 to 2012. Four had chronic infection. Prevalence increased annually from 0 to 6.35%. Risk factors compared with the 2010 CF center cohort included continuous inhaled antibiotics (P = 0.014) and courses of intravenous antibiotics during the year before first isolation (P = 0.009). Hospitalization rates were 1.05/year and 0.47/year preinfection and postinfection, respectively (P = 0.02). Slope of forced expiratory volume at 1 second% predicted remained unchanged during 12 months.
- Published
- 2016
- Full Text
- View/download PDF